Current Ratio of Aligos Therapeutics, Inc. from 30 Jun 2021 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Aligos Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 30 Jun 2021 to 31 Dec 2025.
  • Aligos Therapeutics, Inc. Current Ratio for the quarter ending 31 Dec 2025 was 555%, a 31% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Aligos Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q4 2025 555% +133% +31% 31 Dec 2025
Q3 2025 527% +24% +4.8% 30 Sep 2025
Q2 2025 504% +16% +3.4% 30 Jun 2025
Q1 2025 452% -11% -2.4% 31 Mar 2025
Q4 2024 422% +9.9% +2.4% 31 Dec 2024
Q3 2024 502% +131% +35% 30 Sep 2024
Q2 2024 488% +78% +19% 30 Jun 2024
Q1 2024 463% +8.4% +1.9% 31 Mar 2024
Q4 2023 412% -60% -13% 31 Dec 2023
Q3 2023 371% -132% -26% 30 Sep 2023
Q2 2023 410% -146% -26% 30 Jun 2023
Q1 2023 454% -127% -22% 31 Mar 2023
Q4 2022 473% -201% -30% 31 Dec 2022
Q3 2022 503% -257% -34% 30 Sep 2022
Q2 2022 556% -145% -21% 30 Jun 2022
Q1 2022 582% 31 Mar 2022
Q4 2021 674% 31 Dec 2021
Q3 2021 760% 30 Sep 2021
Q2 2021 701% 30 Jun 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.